Erythema multiforme with tumour necrosis factor inhibitors: a class effect? | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Letter

Erythema multiforme with tumour necrosis factor inhibitors: a class effect?

Authors

T Kain PubMed articles Google scholar articles
D MacGregor PubMed articles Google scholar articles
R R C Buchanan PubMed articles Google scholar articles
J P de Jager PubMed articles Google scholar articles
L Schachna PubMed articles Google scholar articles

Dr Lionel Schachna, Department of Rheumatology, Austin Health, PO Box 5555, Heidelberg, Victoria 3084, Australia; schachna{at}unimelb.edu.au

Citation

Kain T, MacGregor D, Buchanan RRC, et al

Erythema multiforme with tumour necrosis factor inhibitors: a class effect?

Annals of the Rheumatic Diseases 2008;67:899-900.

Publication history

Accepted October 12, 2007
First published May 12, 2008.

Online issue publication

April 13, 2016

Copyright information

2008 BMJ Publishing Group and European League Against Rheumatism